Prostate cancer partial prostatectomy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Prostate Cell Line, Tumor Seminal Vesicles Tumor Cells, Cultured Pelvis Rectum Urethra Chromosomes, Human, Pair 8 Epithelial Cells Neoplastic Stem Cells Penis Neoplastic Cells, Circulating Urinary Bladder Cell Nucleus

Organisms3

Mice, Nude Mice, SCID Mice, Transgenic

Diseases43

Prostatic Neoplasms Prostatic Hyperplasia Adenocarcinoma Urinary Incontinence Prostatic Intraepithelial Neoplasia Neoplasm Recurrence, Local Erectile Dysfunction Disease Progression Neoplasms, Hormone-Dependent Neoplasm Metastasis Neoplasm Invasiveness Prostatic Diseases Bone Neoplasms Genetic Predisposition to Disease Carcinoma Breast Neoplasms Neoplasms Lung Neoplasms Urination Disorders Prostatic Neoplasms, Castration-Resistant Ovarian Neoplasms Prostatitis Colonic Neoplasms Lymphocele Stomach Neoplasms Postoperative Complications Cell Transformation, Neoplastic Urinary Bladder Neoplasms Neovascularization, Pathologic Urinary Bladder Neck Obstruction Pancreatic Neoplasms Lymphatic Metastasis Recurrence Sexual Dysfunction, Physiological Neoplastic Cells, Circulating Colorectal Neoplasms Uterine Cervical Neoplasms Disease Models, Animal Blood Loss, Surgical Urethral Obstruction Urologic Diseases Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung

Chemicals and Drugs57

Prostate-Specific Antigen Androgen Antagonists Receptors, Androgen Androgens Tumor Markers, Biological Tosyl Compounds Antineoplastic Agents, Hormonal Anilides Neoplasm Proteins Flutamide Antineoplastic Agents Finasteride Androgen Receptor Antagonists RNA, Messenger Dihydrotestosterone Glutamate Carboxypeptidase II Racemases and Epimerases Taxoids Goserelin Anticarcinogenic Agents Metribolone PTEN Phosphohydrolase Leuprolide DNA, Neoplasm RNA, Small Interfering Cancer Vaccines 5-alpha Reductase Inhibitors Antigens, Neoplasm Nitriles Testosterone Prostatic Secretory Proteins Estramustine RNA, Neoplasm Testosterone Congeners Kallikreins Antineoplastic Agents, Phytogenic Androstenols 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Tumor Suppressor Protein p53 Glutathione S-Transferase pi Azasteroids Tissue Kallikreins Phenylthiohydantoin Proto-Oncogene Proteins c-akt Oncogene Proteins, Fusion Ki-67 Antigen Transcription Factors Tumor Suppressor Proteins Cholestenone 5 alpha-Reductase MicroRNAs Receptor, erbB-2 Antibodies, Monoclonal Receptors, Estrogen DNA-Binding Proteins Trans-Activators Proto-Oncogene Proteins Enzyme Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment85

Prostatectomy Neoplasm Grading Neoplasm Staging Orchiectomy Transurethral Resection of Prostate Prognosis Early Detection of Cancer Treatment Outcome Laparoscopy Retrospective Studies Nomograms Biopsy, Needle Biopsy Follow-Up Studies Brachytherapy Risk Factors Disease-Free Survival Immunohistochemistry Reverse Transcriptase Polymerase Chain Reaction Digital Rectal Examination Predictive Value of Tests Survival Rate Prospective Studies Survival Analysis Risk Assessment Risk Sensitivity and Specificity Xenograft Model Antitumor Assays Cohort Studies Case-Control Studies Neoplasm Transplantation Multivariate Analysis Gene Expression Profiling Combined Modality Therapy Transplantation, Heterologous Radiotherapy Kaplan-Meier Estimate Blotting, Western SEER Program Tissue Array Analysis Tumor Burden Odds Ratio Incidence Radiotherapy, Conformal Salvage Therapy Reproducibility of Results Proportional Hazards Models Oligonucleotide Array Sequence Analysis Logistic Models Biopsy, Large-Core Needle Questionnaires Registries Antineoplastic Combined Chemotherapy Protocols Radiotherapy Dosage Transfection Polymerase Chain Reaction Radiotherapy, Adjuvant Castration Radiotherapy, Intensity-Modulated Urinary Sphincter, Artificial Immunoenzyme Techniques ROC Curve Mass Screening In Situ Hybridization, Fluorescence Confidence Intervals Drug Screening Assays, Antitumor Molecular Targeted Therapy Models, Biological Preoperative Care Chemotherapy, Adjuvant Preoperative Period Surgery, Computer-Assisted Radiotherapy, Image-Guided Laparoscopes Urinary Catheterization Feasibility Studies Gene Knockdown Techniques Treatment Failure Clinical Trials as Topic Neoadjuvant Therapy Flow Cytometry Disease Models, Animal Lymph Node Excision Organ Size Regression Analysis

Psychiatry and Psychology2

Erectile Dysfunction Learning Curve

Phenomena and Processes41

Gene Expression Regulation, Neoplastic Nomograms Cell Proliferation Apoptosis Genetic Predisposition to Disease Risk Sensitivity and Specificity Time Factors Penile Erection Odds Ratio Signal Transduction Cell Growth Processes Drug Resistance, Neoplasm Genotype Cell Division Down-Regulation Gene Fusion Cell Survival DNA Methylation Cell Movement Transfection Chromosomes, Human, Pair 8 Up-Regulation Dose-Response Relationship, Drug Promoter Regions, Genetic Cell Cycle Oncogene Fusion Polymorphism, Genetic Mutation Gene Silencing Genes, Tumor Suppressor RNA Interference Gene Expression Polymorphism, Single Nucleotide Base Sequence Phosphorylation Diet Alleles Transcription, Genetic Organ Size Genes, Neoplasm

Disciplines and Occupations3

Robotics Urology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life National Cancer Institute (U.S.)Forecasting

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science11

Robotics Survival Rate SEER Program Incidence Radiotherapy, Conformal Questionnaires Registries Radiotherapy, Intensity-Modulated Surgery, Computer-Assisted Base Sequence Molecular Sequence Data

Named Groups5

European Continental Ancestry Group African Americans African Continental Ancestry Group Survivors Asian Continental Ancestry Group

Health Care37

Watchful Waiting Treatment Outcome Retrospective Studies Nomograms Follow-Up Studies Risk Factors Disease-Free Survival Predictive Value of Tests Survival Rate Prospective Studies Survival Analysis Risk Assessment Risk Sensitivity and Specificity Cohort Studies Case-Control Studies Multivariate Analysis Kaplan-Meier Estimate SEER Program Odds Ratio Incidence Age Factors Reproducibility of Results Proportional Hazards Models Logistic Models Questionnaires Registries National Cancer Institute (U.S.)ROC Curve Mass Screening Confidence Intervals Preoperative Care Preoperative Period Feasibility Studies Treatment Failure Clinical Trials as Topic Regression Analysis

Geographicals4

United States Japan Sweden Scandinavia

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Prostatectomy Prostate Prostatic Neoplasms Prostate-Specific Antigen Androgen Antagonists Robotics Prostatic Hyperplasia Receptors, Androgen Androgens Cell Line, Tumor Neoplasm Grading Neoplasm Staging Adenocarcinoma Urinary Incontinence Tumor Markers, Biological Prostatic Intraepithelial Neoplasia Neoplasm Recurrence, Local Erectile Dysfunction Gene Expression Regulation, Neoplastic Orchiectomy Disease Progression Transurethral Resection of Prostate Watchful Waiting Neoplasms, Hormone-Dependent Prognosis Tosyl Compounds Neoplasm Metastasis Early Detection of Cancer Neoplasm Invasiveness Treatment Outcome Prostatic Diseases Laparoscopy Antineoplastic Agents, Hormonal Urology Retrospective Studies Nomograms Mice, Nude Seminal Vesicles Biopsy, Needle Biopsy Follow-Up Studies Brachytherapy Risk Factors Bone Neoplasms Anilides Disease-Free Survival Immunohistochemistry Cell Proliferation Reverse Transcriptase Polymerase Chain Reaction Tumor Cells, Cultured Neoplasm Proteins Flutamide Apoptosis Antineoplastic Agents Digital Rectal Examination Genetic Predisposition to Disease Predictive Value of Tests Survival Rate Prospective Studies Finasteride Androgen Receptor Antagonists Survival Analysis Risk Assessment Risk Sensitivity and Specificity RNA, Messenger Carcinoma Xenograft Model Antitumor Assays Time Factors Cohort Studies United States Case-Control Studies Neoplasm Transplantation Dihydrotestosterone Multivariate Analysis Gene Expression Profiling Combined Modality Therapy Pelvis Breast Neoplasms Glutamate Carboxypeptidase II Transplantation, Heterologous Radiotherapy Kaplan-Meier Estimate Blotting, Western SEER Program Racemases and Epimerases Neoplasms Tissue Array Analysis Penile Erection Taxoids Goserelin Anticarcinogenic Agents Metribolone Tumor Burden Odds Ratio Quality of Life Incidence Lung Neoplasms Signal Transduction Cell Growth Processes

No FAQ available that match "prostate cancer partial prostatectomy"